USA
Meldepflichtige Eigengeschäfte von Führungskräften (Directors' Dealings) gemäß Art. 19 MAR – wer im eigenen Unternehmen kauft und verkauft.
Datenstand: 23.10.2026 (gestern)
| Gemeldet ↓ | Geschäft | Unternehmen | Insider | Position | Art | Volumen |
|---|---|---|---|---|---|---|
| 06.10.2026 | 06.10.2026 | Crowdstrike Holdings, Inc. | George Kurtz | PRESIDENT AND CEO / Director | Verkauf | 1.060.580,00 USD |
| 06.10.2026 | 06.10.2026 | Crowdstrike Holdings, Inc. | George Kurtz | PRESIDENT AND CEO / Director | Verkauf | 334.020,00 USD |
| 06.10.2026 | 06.10.2026 | Crowdstrike Holdings, Inc. | George Kurtz | PRESIDENT AND CEO / Director | Verkauf | 33.242,40 USD |
| 06.10.2026 | 08.10.2026 | Adaptive Biotechnologies Corp. | Julie Rubinstein | President and COO | Verkauf | 304.866,46 USD |
| 06.10.2026 | 07.10.2026 | Adaptive Biotechnologies Corp. | Julie Rubinstein | President and COO | Verkauf | 313.658,40 USD |
| 06.10.2026 | 06.10.2026 | Adaptive Biotechnologies Corp. | Julie Rubinstein | President and COO | Verkauf | 15.234,47 USD |
| 06.10.2026 | 06.10.2026 | Adaptive Biotechnologies Corp. | Julie Rubinstein | President and COO | Verkauf | 26.768,71 USD |
| 06.10.2026 | 06.10.2026 | Adaptive Biotechnologies Corp. | Julie Rubinstein | President and COO | Verkauf | 31.031,00 USD |
| 06.10.2026 | 06.10.2026 | Adaptive Biotechnologies Corp. | Julie Rubinstein | President and COO | Verkauf | 256.664,16 USD |
| 06.10.2026 | 07.10.2026 | Sailpoint, Inc. | Matt Mills | President | Verkauf | 3.331,72 USD |
| 06.10.2026 | 07.10.2026 | Sailpoint, Inc. | Matt Mills | President | Verkauf | 833.310,63 USD |
| 06.10.2026 | 06.10.2026 | Sailpoint, Inc. | Matt Mills | President | Verkauf | 92.133,74 USD |
| 06.10.2026 | 06.10.2026 | Sailpoint, Inc. | Matt Mills | President | Verkauf | 685.896,12 USD |
| 06.10.2026 | 06.10.2026 | Anteris Technologies Global Corp. | L1 Capital Pty Ltd | 10% Owner | Kauf | 1.957.950,10 USD |
| 06.10.2026 | 07.10.2026 | Sailpoint, Inc. | Christopher Schmitt | General Counsel and Secretary | Verkauf | 1.839,60 USD |
| 06.10.2026 | 07.10.2026 | Sailpoint, Inc. | Christopher Schmitt | General Counsel and Secretary | Verkauf | 458.785,01 USD |
| 06.10.2026 | 06.10.2026 | Sailpoint, Inc. | Christopher Schmitt | General Counsel and Secretary | Verkauf | 50.725,08 USD |
| 06.10.2026 | 06.10.2026 | Sailpoint, Inc. | Christopher Schmitt | General Counsel and Secretary | Verkauf | 377.605,66 USD |
| 06.10.2026 | 06.10.2026 | Adaptive Biotechnologies Corp. | Susan Bobulsky | Chief Commercial Officer, MRD | Verkauf | 193.320,00 USD |
| 06.10.2026 | 06.10.2026 | Arqit Quantum Inc. | Andrew Leaver | Chief Executive Officer | Verkauf | 58.011,22 USD |
| 06.10.2026 | 06.10.2026 | Arqit Quantum Inc. | Paul Feenan | Chief Revenue Officer | Verkauf | 12.192,52 USD |
| 06.10.2026 | 06.10.2026 | Arqit Quantum Inc. | Patrick Willcocks | General Counsel | Verkauf | 13.426,28 USD |
| 06.10.2026 | 06.10.2026 | Arqit Quantum Inc. | Garth Ritchie | Director | Verkauf | 2.854,60 USD |
| 06.10.2026 | 06.10.2026 | Arqit Quantum Inc. | Nicholas William Nilan | General Manager-US | Verkauf | 11.926,41 USD |
| 06.10.2026 | 06.10.2026 | Arqit Quantum Inc. | Ben Simon Wilder | Chief Operating Officer | Verkauf | 5.273,75 USD |
| 06.10.2026 | 07.10.2026 | Remitly Global, Inc. | Joshua Hug | Director | Verkauf | 126.885,00 USD |
| 06.10.2026 | 06.10.2026 | Remitly Global, Inc. | Joshua Hug | Director | Verkauf | 127.490,00 USD |
| 06.10.2026 | 07.10.2026 | Sailpoint, Inc. | Mitra Rezvan | Chief Accounting Officer | Verkauf | 347,48 USD |
| 06.10.2026 | 07.10.2026 | Sailpoint, Inc. | Mitra Rezvan | Chief Accounting Officer | Verkauf | 88.181,65 USD |
| 06.10.2026 | 06.10.2026 | Sailpoint, Inc. | Mitra Rezvan | Chief Accounting Officer | Verkauf | 6.267,03 USD |
| 06.10.2026 | 06.10.2026 | Sailpoint, Inc. | Mitra Rezvan | Chief Accounting Officer | Verkauf | 46.574,94 USD |
| 06.10.2026 | 08.10.2026 | Inmed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC | 10% Owner | Kauf | 2.996,64 USD |
| 06.10.2026 | 07.10.2026 | Inmed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC | 10% Owner | Kauf | 4.051,18 USD |
| 06.10.2026 | 06.10.2026 | Inmed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC | 10% Owner | Kauf | 7.436,45 USD |
| 06.10.2026 | 07.10.2026 | Sailpoint, Inc. | Abby Payne | Chief People Officer | Verkauf | 1.655,64 USD |
| 06.10.2026 | 07.10.2026 | Sailpoint, Inc. | Abby Payne | Chief People Officer | Verkauf | 412.841,47 USD |
| 06.10.2026 | 06.10.2026 | Sailpoint, Inc. | Abby Payne | Chief People Officer | Verkauf | 45.635,75 USD |
| 06.10.2026 | 06.10.2026 | Sailpoint, Inc. | Abby Payne | Chief People Officer | Verkauf | 339.806,58 USD |
| 06.10.2026 | 07.10.2026 | Sailpoint, Inc. | Chandrasekar Gnanasambandam | EVP Product & CTO | Verkauf | 1.778,28 USD |
| 06.10.2026 | 07.10.2026 | Sailpoint, Inc. | Chandrasekar Gnanasambandam | EVP Product & CTO | Verkauf | 443.904,12 USD |
| 06.10.2026 | 06.10.2026 | Sailpoint, Inc. | Chandrasekar Gnanasambandam | EVP Product & CTO | Verkauf | 31.524,42 USD |
| 06.10.2026 | 06.10.2026 | Sailpoint, Inc. | Chandrasekar Gnanasambandam | EVP Product & CTO | Verkauf | 234.678,54 USD |
| 06.10.2026 | 06.10.2026 | Butterfly Network, Inc. | Joseph Devivo | President & CEO / Director | Verkauf | 358.615,80 USD |
| 06.10.2026 | 06.10.2026 | Oklo Inc. | Vivek Narayanadas | General Counsel & Secretary | Verkauf | 10.739,52 USD |
| 06.10.2026 | 06.10.2026 | Central Securities Corp. | John C. Hill | CEO & President / Director | Kauf | 28.185,00 USD |
| 06.10.2026 | 06.10.2026 | Horace Mann Educators Corp. | Marita Zuraitis | President & CEO / Director | Verkauf | 4.600,00 USD |
| 06.10.2026 | 06.10.2026 | Darden Restaurants Inc. | Melvin John Martin | Group President | Verkauf | 447.565,49 USD |
| 06.10.2026 | 06.10.2026 | Blackrock Esg Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% Owner | Verkauf | 131.193,36 USD |
| 06.10.2026 | 06.10.2026 | Pimco Dynamic Income Strategy Fund | Saba Capital Management, L.P. | 10% Owner | Verkauf | 290.781,48 USD |
| 06.10.2026 | 06.10.2026 | Gabelli Healthcare & Wellnessrx Trust | Saba Capital Management, L.P. | 10% Owner | Kauf | 41.770,99 USD |